Walleye Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
+9,900
New +$2.6M 0.01% 1249
2026
Q1
Sell
-900
Closed -$226K 4702
2025
Q4
$226K Sell
900
-700
-44% -$186K ﹤0.01% 3477
2025
Q3
$459K Sell
1,600
-600
-27% -$161K ﹤0.01% 2683
2025
Q2
$578K Sell
2,200
-1,500
-41% -$365K ﹤0.01% 2512
2025
Q1
$861K Sell
3,700
-7,700
-68% -$1.87M ﹤0.01% 2097
2024
Q4
$2.61M Buy
11,400
+4,000
+54% +$918K 0.01% 1536
2024
Q3
$1.65M Sell
7,400
-600
-8% -$132K ﹤0.01% 2149
2024
Q2
$1.63M Sell
8,000
-100
-1% -$20.3K ﹤0.01% 2313
2024
Q1
$1.77M Buy
8,100
+4,200
+108% +$925K ﹤0.01% 2081
2023
Q4
$886K Buy
3,900
+300
+8% +$63K ﹤0.01% 2456
2023
Q3
$724K Buy
3,600
+3,134
+673% +$661K ﹤0.01% 2516
2023
Q2
$96.5K Buy
+466
New +$90.4K ﹤0.01% 3448
2019
Q4
Sell
-10,360
Closed -$1.5M 2050
2019
Q3
$1.5M Buy
+10,360
New +$1.51M 0.09% 308

Other funds holding LH

Walleye Capital's LH Position: Q2 2026 in Review

Walleye Capital opened a new position in Labcorp (LH) in Q2 2026: 47 shares worth $13.2K. The stake represents ﹤0.01% of the portfolio and ranks #4460 among its holdings. This is a return to the name: Walleye Capital previously reported a position in LH as recently as Q3 2025.

Walleye Capital first reported a position in LH in Q3 2019 and has held it in 12 quarters since. The position peaked at $13.1M in Q3 2024. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Walleye Capital held 47 shares of Labcorp worth $13.2K as of Q2 2026.
  • Labcorp was a new Walleye Capital position in Q2 2026.
  • Labcorp made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4460 holding.
  • Walleye Capital first reported a position in Labcorp in Q3 2019 and has held it in 12 quarters since.
  • Walleye Capital's Labcorp position peaked at $13.1M in Q3 2024.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.